Immunome (IMNM) Common Equity (2019 - 2026)
Immunome (IMNM) recorded Common Equity of $525.08 million in Q2 2026, up 95.0% from $269.27 million a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunome reported Common Equity of $634.34 million, up 250.1% from FY2024.
- Annual Common Equity has increased for three straight years, with a five-year compound annual growth rate of 72.7% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $181.17 million in FY2024 (+51.1%), $119.88 million in FY2023 (+619.9%), $16.65 million in FY2022 (-65.4%) and $48.19 million in FY2021 (+16.5%).
- Quarterly Common Equity has ranged from $6.08 million in Q3 2023 to $634.34 million in Q4 2025 over the past five years.
- On a year-over-year basis, Common Equity has increased for seven consecutive quarters, with growth averaging 74.9% over the last seven quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 619.9% in Q4 2023, against a decline of 73.7% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $588.69 million (Q1 2026), $634.34 million (Q4 2025) and $263.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Immunome | 2.46 Bn | 429.67 Mn | - | 525.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 525.08 Mn |
| Mar 31, 2026 | 588.69 Mn |
| Dec 31, 2025 | 634.34 Mn |
| Sep 30, 2025 | 263.92 Mn |
| Jun 30, 2025 | 269.27 Mn |
| Mar 31, 2025 | 307.13 Mn |
| Dec 31, 2024 | 181.17 Mn |
| Sep 30, 2024 | 214.91 Mn |
| Jun 30, 2024 | 253.84 Mn |
| Mar 31, 2024 | 285.57 Mn |
| Dec 31, 2023 | 119.88 Mn |
| Sep 30, 2023 | 6.08 Mn |
| Jun 30, 2023 | 9.34 Mn |
| Mar 31, 2023 | 13.86 Mn |
| Dec 31, 2022 | 16.65 Mn |
| Sep 30, 2022 | 23.08 Mn |
| Jun 30, 2022 | 30.28 Mn |
| Mar 31, 2022 | 37.87 Mn |
| Dec 31, 2021 | 48.19 Mn |
| Sep 30, 2021 | 54.79 Mn |
API Access
Immunome Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();